The Psychobiology of Childhood Temperament
The Psychobiology of Temperament: An fMRI Study
2 other identifiers
observational
550
1 country
1
Brief Summary
The purpose of this study is to use brain imaging technology to examine brain changes that occur in children when they are exposed to various kinds of emotional tasks and to determine if these changes are related to the child's temperament. Studies suggest that the risk for developing mood and anxiety disorders in preschool children may be linked to differences in temperament. The relationship between temperament and risk or resilience may reflect the influences of brain activity on behavior at different stages of childhood development. Behavioral inhibition and mood or anxiety disorders have been linked to disturbances in the circuitry of several areas in the brain. However, the involvement of this circuitry in temperament remains unclear. This study will use functional magnetic resonance imaging (fMRI) to examine the function of different parts of the brain in children who have previously undergone temperament studies and have had their temperaments classified. Two sets of studies will be performed in the current protocol. A small set of pilot studies will be performed in infants, by staff at the University of Maryland. In terms of the studies among infants, these subjects will initially be contacted by staff at Maryland and then will be seen at the NIH for up to three visits lasting between 4- to 5- hours during the first year of life. These subjects also will undergo visits at the University of Maryland throughout the first year of life. This study will comprise up to four clinic visits. At Visit 1, children and their parents will meet with study staff individually and together for psychiatric interviews. Children will undergo a physical examination, medical history, a urine drug test, and practice in an fMRI simulator. Saliva samples will be collected from the children and tests will be given to assess stage of puberty, temperament, intelligence, feelings, experiences, and behavior. Other visits include fMRI scans of the brain and other tasks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2003
CompletedFirst Posted
Study publicly available on registry
May 13, 2003
CompletedStudy Start
First participant enrolled
November 10, 2003
CompletedMarch 31, 2026
December 23, 2025
May 12, 2003
March 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Task performance
Task performance on paradigms used in the scanner or in the clinic
Up to 4 visits, though age 29
fMRI BOLD signal
MRI BOLD signal changes in response to different paradigms testing different processes including threat, reward, social processes, conditioning, and attention
Up to 4 visits, though age 29
Study Arms (3)
Non-Targets
Characterized by temperament - no behavioral inhibition
Parents
Parents of children enrolled in the study
Targets
Characterized by temperament - high/low behavioral inhibition
Eligibility Criteria
Community sample
You may qualify if:
- Consent: Can give consent/assent.
- Age: 2 months-14 months; 7-60 years
- Children in Cohort 4: Age: 9-11 years
- IQ: All subjects will have IQ greater than 70. (exception: infants will not need to meet this criteria)
- Psychopathology: all subjects will be free of lifetime history of psychosis and pervasive developmental disorder
- Specific to infant cohort: between the ages of 4 and 14 months of age and is free of any known developmental disability or medical condition
You may not qualify if:
- Any chronic or acute medical condition severe enough to interfere with task performance or completion of questionnaires; Any medical condition that increases risk for MRI (e.g. pacemaker, metallic foreign body in eye, dental braces)
- Any medical condition that increases risk for MRI (e.g. pacemaker, metallic foreign body in eye, dental braces).
- Any current axis I psychiatric disorder necessitating acute treatment.
- Claustrophobia
- Pregnancy
- Specific to infant cohort:
- Was born prematurely, before 36 weeks gestation
- Had a birth weight significantly below normal for gestational age
- Has any known developmental disability or medical condition
- Has any metallic objects in their body (e.g., Has implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and cochlear implants), implanted delivery pump,
- Comes from a home where the primary language spoken is not English
- NIMH employees and staff and their immediate family members will be excluded from the study per NIMH policy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel S Pine, M.D.
National Institute of Mental Health (NIMH)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2003
First Posted
May 13, 2003
Study Start
November 10, 2003
Last Updated
March 31, 2026
Record last verified: 2025-12-23
Data Sharing
- IPD Sharing
- Will not share